Scholars Central

Conference abstract

Biosimilar market overview, present and future

Authors: Leandro Mieravilla

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Analyzed present and future actions of main players in biosimilar market in different regions of the world. After many years in the slow lane, changes are driving new momentum in the market for biosimilars. Strategies of main players oriented to growth in a new market. Patents for the first generation of approved biopharmaceuticals have either expired or are about to expire which open new opportunities at biopharmaceutical market. Thus the market is opening for generic versions, referred to as ?biosimilars? (European Union) or ?follow-on protein products? (United States). Healthcare professionals need to understand the critical issues surrounding the use of biosimilars to make informed treatment decisions. Cassara Biotech global development on biosimilar and biotechnology market. Biosimilars present a new set of challenges for regulatory authorities when compared with conventional generics.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Bioequivalence & Bioavailability.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Bioequivalence & Bioavailability
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Leandro Mieravilla”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels